Clinicians will soon be able to treat patients with advanced Alzheimer?s disease (AD) using the first drug approved for use in the later stages of this progressive condition. The FDA recently approved memantine (Namenda, Forest Laboratories) for the treatment of moderate to severe AD. The drug will be available in pharmacies January.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.